SCHEMBL26862768

SCHEMBL26862768

CC(C)Oc1cccc(OC(C)C)c1OC(=O)c1cccc(CNCC(=O)N(C)CCN(C)C)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM5A P29375 2/20 0.46
▸ KDM5C P41229 2/20 0.46
▸ KDM5B Q9UGL1 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ KDM4C Q9H3R0 1/20 0.36
▸ MEP1B Q16820 1/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ SENP1 Q9P0U3 2/20 0.35
▸ PARP1 P09874 1/20 0.34
▸ LOXL2 Q9Y4K0 1/20 0.33
▸ ROCK2 O75116 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ CYP4F2 P78329 1/20 0.33
▸ CYP4A11 Q02928 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716654 0.85 KDM5B (0.64) KDM5AKDM5CKDM5BKDM4EALDH1A1
SCHEMBL26862853 0.79 KDM5B (0.73) KDM5AKDM5CKDM5BKDM4CSENP1
SCHEMBL16291539 0.77 KDM5B (0.77) KDM5AKDM5CKDM5BKDM4EALDH1A1
SCHEMBL26862778 0.76 KDM5B (0.49) KDM5AKDM5CKDM5BKDM4EALDH1A1
SCHEMBL21716656 0.74 KDM5B (0.59) KDM5AKDM5CKDM5BKDM4EALDH1A1
SCHEMBL26862781 0.73 KDM5B (0.46) KDM5AKDM5CKDM5BALDH1A1KDM4C
SCHEMBL16912751 0.70 KDM5B (0.55) KDM5AKDM5CKDM5BKDM4EALDH1A1
SCHEMBL21716662 0.68 KDM5B (0.84) KDM5AKDM5CKDM5BKDM4EALDH1A1
SCHEMBL26862784 0.65 KDM5B (0.71) KDM5AKDM5CKDM5BKDM4EALDH1A1
SCHEMBL1471037 0.65 HIF1A (0.49) KDM4EALDH1A1HTR1ASENP1LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382865-A1 HISTONE DEMETHYLASE 5 INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382865-A1 HISTONE DEMETHYLASE 5 INHIBITORS AND USES THEREOF KDM5A, KDM5B, KDM5C KDM5A 1/4885KDM5C 3/4885KDM5B 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback